Cover Image

High Expression of NTRK1 in ETV6::RUNX1 Positive Acute Lymphoblastic Leukaemia Drives Factor Independence and Sensitivity to Larotrectinib

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Luke Quinlan, Elyse C. Page, Jacqueline Rehn, Barbara J. McClure, Michael P. Osborn, Andrew S. Moore, Rishi S. Kotecha, Michelle J. Henderson, Michelle Martin, Frank Alvaro, David T. Yeung, Deborah L. White, Susan L. Heatley
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pediatric Blood & Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Secondary T‐Lymphoblastic Lymphoma With KMT2A::MAML2 Rearrangement Following Myeloid Sarcoma and RUNX1::RUNX1T1‐Positive Acute Myeloid Leukemia
by: Ting Li, et al.
Published: (2026)

Synchronous B‐Cell Precursor Acute Lymphoblastic Leukaemia and Wilms Tumour in a Patient With Lateralised Overgrowth: Causation or Coincidence?
by: Karolina Miarka‐Walczyk, et al.
Published: (2025)

Homoharringtonine in Relapsed/Refractory Paediatric T‐Cell Acute Lymphoblastic Leukaemia—A Case Series and a Report on the Use of In Vitro Drug Profiling
by: Pui Yung Grace Tong, et al.
Published: (2025)

Attitudes Toward COVID‐19 Vaccination Among Pediatric Acute Lymphoblastic Leukemia Patients and Their Caregivers
by: Janna R. Shapiro, et al.
Published: (2025)

Intestinal Spindle Cell Neoplasm With TPM4::NTRK1 Kinase Gene Fusion: A First Case Report in the Infantile Population
by: Anais Fohn, et al.
Published: (2025)

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia
by: Janna R. Shapiro, et al.
Published: (2026)

Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
by: Alda Daniela García‐Guzmán, et al.
Published: (2025)

Multidisciplinary Approach to the Diagnosis and Treatment of Ewing Sarcoma of the Kidney With an Extremely Rare FUS::ETV4 Genetic Rearrangement
by: Natalia D. Faseeva, et al.
Published: (2025)

Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia
by: Seth E. Karol, et al.
Published: (2025)

Two Faces of NOTCH1 in Childhood Lymphoblastic T‐Cell Neoplasia: Prognostic Divergence of Mutational and Structural Aberrations
by: Marie C. Heider, et al.
Published: (2026)

Invasive fungal disease in children with solid tumors: An Australian multicenter 10‐year review
by: Neha Jain, et al.
Published: (2024)

Therapeutic Response to Imatinib in Bilateral Infiltrative and Leukostatic Retinopathy in Chronic Myelogenous Leukaemia
by: Anamika Patel, et al.
Published: (2025)

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience
by: Thomas J. Jackson, et al.
Published: (2026)

Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
by: Ashley C. Holland, et al.
Published: (2025)

Waardenburg Syndrome With T‐Lymphoblastic Lymphoma: A Case Report
by: Neha Da Rocha, et al.
Published: (2025)

Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single‐Center Study
by: Amrutha Narayana Murthy, et al.
Published: (2025)

Pediatric Mixed Phenotype Acute Leukemia With ETV6 :: ARNT Fusion Gene Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation
by: Yaoyao Rui, et al.
Published: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
by: Mikhail Lemeshev, et al.
Published: (2026)

Monosomy 10 Mosaicism as an Incidental Finding in Acute Lymphoblastic Leukemia
by: Dany Assaf Curi, et al.
Published: (2025)

A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
by: Cassandra Grello, et al.
Published: (2025)

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West
by: Angela Parra del Riego, et al.
Published: (2026)

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia
by: Laura Almási, et al.
Published: (2026)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
by: Andrew E. Place, et al.
Published: (2025)

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
by: Nirali N. Shah, et al.
Published: (2025)

Blinatumomab‐Associated Psychosis in an Adolescent With B‐Cell Acute Lymphoblastic Leukemia
by: Eesha A. Zaheer, et al.
Published: (2026)

Management of Philadelphia Chromosome‐Positive B‐Lymphoblastic Leukemia Diagnosed in an Infant
by: Jessica A. O. Zimmerman, et al.
Published: (2025)

Non‐Promyelocytic Acute Myeloid Leukaemia With Budd–Chiari Syndrome: A Rare Concurrence in a Child
by: Neha Da Rocha, et al.
Published: (2026)

Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium
by: Emily J. Mason, et al.
Published: (2026)

B‐Lymphoblastic Leukemia With TCF3::PBX1 Fusion Presenting a Mature B‐Cell Phenotype and Lambda Light‐Chain Restriction
by: Xiuyun Zhao, et al.
Published: (2025)

Pediatric B‐Cell Acute Lymphoblastic Leukemia With FUS::FLI1 Fusion in an Infant With Measurable Residual Disease: Sustained Molecular Remission Achieved With Blinatumomab
by: Qiang Yao, et al.
Published: (2025)

Disseminated Infection Following the Administration of the Varicella Vaccine in a Child with Acute Lymphoblastic Leukemia
by: Ryo Hanaki, et al.
Published: (2025)

Use of Oral Metformin Therapy for Therapy‐Induced Hyperglycemia in Pediatric Patients With Acute Lymphoblastic Leukemia
by: Ankita Chakraborty, et al.
Published: (2026)

Reduced‐Intensity Chemotherapy With Immunotherapy for Children With Down Syndrome and B‐Cell Acute Lymphoblastic Leukemia
by: Ashley C. Holland, et al.
Published: (2025)

Venetoclax Plus Daratumumab Bridging Allo‐HSCT in Early T‐Cell Precursor Acute Lymphoblastic Leukemia
by: Fanqiao Meng, et al.
Published: (2025)

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia
by: Kellee N. Parker, et al.
Published: (2026)

Caregiving for Children With Acute Lymphoblastic Leukemia Receiving Home‐Based Blinatumomab: Caregiver Experiences and Recommendations
by: Sue Zupanec, et al.
Published: (2025)

Late Onset Blinatumomab‐Related Neurotoxicity in a Child With B‐Cell Acute Lymphoblastic Leukemia
by: Krunal Shah, et al.
Published: (2025)

A Rare Case of Infant B‐ALL With SIN3A::NUTM1 Fusion: Durable Molecular Remission Achieved With Standard Acute Lymphoblastic Leukemia Chemotherapy
by: Dong Peng, et al.
Published: (2026)

Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
by: Marko Kavcic, et al.
Published: (2025)

Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels
by: Aida Zeckanovic, et al.
Published: (2024)